New York
Josh has been named American Lawyer's “Litigator of the Year” twice, in addition to being a finalist for 2022 and 2025. In 2012, the magazine dubbed him “the Defibrillator” based on his streak of appellate wins for companies that “appeared to be at death’s door,” and in 2017 it declared, he “still deserves the moniker we once gave him.”
In 2014, The Financial Times named Josh one of the 10 most innovative lawyers in the North American legal sector for his work “demystify[ing] the technical issues” and securing a victory in the blockbuster Federal Circuit appeal, Oracle v. Google. Chambers USA has reported, “He wins accolades for his ‘brilliant analysis and judgment.’ Clients appreciate how he ‘rethinks every case from the ground up,’ and add: ‘He can take the most complicated legal or technological issue and present it in a way that seems like common sense.’” Another edition of Chambers USA added: “‘His briefs are quite simply beautiful,’” and “clients describe his courtroom presence as ‘both commanding and accessible at the same time.’ He has the ‘perfect combination of persuasiveness, intelligence, wit, and deference.’”
Josh's practice covers a wide range of subjects, including intellectual property, financial services, securities, privacy, antitrust, federal preemption, insurance law, corporate governance, criminal law, and constitutional litigation. Among his recent clients are Cisco, Credit Suisse, Cox Communications, DISH Network, Genentech, Gilead, Johnson & Johnson, JPMorgan Chase, Microsoft, Mozilla, Oracle, Sonos, and Royal Bank of Scotland.
Clients turn to Josh to win the highest stakes appeals, including appeals in cases that threaten the very survival of a business. For example:
Josh was the founding president and CEO of the Brennan Center for Justice at New York University School of Law, one of the country’s foremost public interest firms. Over the course of eight years, he was the Brennan Center’s chief strategist on litigation and public policy advocacy. Before that, Josh founded the Office of the Appellate Defender, a public defender office specializing in criminal appeals.
New York
Josh has been named American Lawyer's “Litigator of the Year” twice, in addition to being a finalist for 2022 and 2025. In 2012, the magazine dubbed him “the Defibrillator” based on his streak of appellate wins for companies that “appeared to be at death’s door,” and in 2017 it declared, he “still deserves the moniker we once gave him.”
In 2014, The Financial Times named Josh one of the 10 most innovative lawyers in the North American legal sector for his work “demystify[ing] the technical issues” and securing a victory in the blockbuster Federal Circuit appeal, Oracle v. Google. Chambers USA has reported, “He wins accolades for his ‘brilliant analysis and judgment.’ Clients appreciate how he ‘rethinks every case from the ground up,’ and add: ‘He can take the most complicated legal or technological issue and present it in a way that seems like common sense.’” Another edition of Chambers USA added: “‘His briefs are quite simply beautiful,’” and “clients describe his courtroom presence as ‘both commanding and accessible at the same time.’ He has the ‘perfect combination of persuasiveness, intelligence, wit, and deference.’”
Josh's practice covers a wide range of subjects, including intellectual property, financial services, securities, privacy, antitrust, federal preemption, insurance law, corporate governance, criminal law, and constitutional litigation. Among his recent clients are Cisco, Credit Suisse, Cox Communications, DISH Network, Genentech, Gilead, Johnson & Johnson, JPMorgan Chase, Microsoft, Mozilla, Oracle, Sonos, and Royal Bank of Scotland.
Clients turn to Josh to win the highest stakes appeals, including appeals in cases that threaten the very survival of a business. For example:
Josh was the founding president and CEO of the Brennan Center for Justice at New York University School of Law, one of the country’s foremost public interest firms. Over the course of eight years, he was the Brennan Center’s chief strategist on litigation and public policy advocacy. Before that, Josh founded the Office of the Appellate Defender, a public defender office specializing in criminal appeals.
San Francisco
Ramy advises public and private companies and their financial sponsors in the technology and life sciences sectors on complex, strategic transactions, including cross-border M&A, joint ventures, and multi-jurisdictional carve-outs. He also counsels boards and investors on fiduciary duties and other corporate governance matters.
Ramy is a member of the board of directors of Crisis Text Line, a global not-for-profit organization providing free mental health texting service. He has been recognized as a "Rising Star" in M&A by Super Lawyers.
Select Transactions
San Francisco
Ramy advises public and private companies and their financial sponsors in the technology and life sciences sectors on complex, strategic transactions, including cross-border M&A, joint ventures, and multi-jurisdictional carve-outs. He also counsels boards and investors on fiduciary duties and other corporate governance matters.
Ramy is a member of the board of directors of Crisis Text Line, a global not-for-profit organization providing free mental health texting service. He has been recognized as a "Rising Star" in M&A by Super Lawyers.
Select Transactions
London
Her expertise includes the creation of both equity-based and cash-based incentive plans, including the full range of HMRC tax-advantaged plans such as EMI plans and CSOPs, working on the incentives aspects of corporate transactions, including both venture capital and private equity investment, public company takeovers, IPOs, and company reorganizations. She considers the impact of the transaction on the share plans for employees and implements new incentive arrangements following investment into companies and businesses. She also guides listed companies on how to reward their executive directors in accordance with market practice and best corporate governance.
Rebecca is a member of the Share Plan Lawyers Organisation and a contributor to various publications (such as the Practical Law Company). She received a band 5 ranking in Employee Share Schemes & Incentives by Chambers UK 2025, is a “Leading Individual” under The Legal 500’s legal directory and has been recognized by MergerLinks as one of the top 30 most active up-and-coming tax lawyers in EMEA.
London
Her expertise includes the creation of both equity-based and cash-based incentive plans, including the full range of HMRC tax-advantaged plans such as EMI plans and CSOPs, working on the incentives aspects of corporate transactions, including both venture capital and private equity investment, public company takeovers, IPOs, and company reorganizations. She considers the impact of the transaction on the share plans for employees and implements new incentive arrangements following investment into companies and businesses. She also guides listed companies on how to reward their executive directors in accordance with market practice and best corporate governance.
Rebecca is a member of the Share Plan Lawyers Organisation and a contributor to various publications (such as the Practical Law Company). She received a band 5 ranking in Employee Share Schemes & Incentives by Chambers UK 2025, is a “Leading Individual” under The Legal 500’s legal directory and has been recognized by MergerLinks as one of the top 30 most active up-and-coming tax lawyers in EMEA.
San Francisco
San Francisco
Eric counsels private and public companies, including private equity funds, on the tax aspects of their most important business transactions, including domestic and cross-border mergers and acquisitions, investments, joint ventures, and restructurings. In particular, Eric has significant experience with the tax matters most critical to clients in the technology and life science sectors. Eric also has significant experience advising clients on equity and other compensation tax matters, real estate tax matters and tax controversy matters.
Eric began his career at the firm as a summer associate in 2001.
San Francisco
San Francisco
Eric counsels private and public companies, including private equity funds, on the tax aspects of their most important business transactions, including domestic and cross-border mergers and acquisitions, investments, joint ventures, and restructurings. In particular, Eric has significant experience with the tax matters most critical to clients in the technology and life science sectors. Eric also has significant experience advising clients on equity and other compensation tax matters, real estate tax matters and tax controversy matters.
Eric began his career at the firm as a summer associate in 2001.
Boston
Amy works with digital health companies, health systems and other public and private companies—from new entrants to seasoned organizations—to address regulatory compliance and transactional needs. She also advises investors and collaborates with clients to understand their business goals and tailor practical solutions to help them achieve those objectives. Amy is well-versed in the corporate governance, data privacy, and security and scope-of-practice considerations facing the healthcare industry as it incorporates artificial intelligence (AI) and machine-learning (ML) solutions into clinical workflows. Her practice includes structuring and scaling national telehealth practices across a range of clinical disciplines, including complex collaborative arrangements involving labs, medical device manufacturers, remote patient monitoring solutions and pharmacies.
Amy spends much of her time working with clients on vetting and developing strategic affiliations, joint venture transactions and other novel business arrangements, including developing value-based enterprises and otherwise identifying means to achieve further alignment among stakeholders. She advises on reimbursement issues with respect to federal healthcare programs, private payors and self-pay business models. She also helps develop compliance programs and advises on related protocols and best practices.
In particular, Amy advises on physician self-referral, anti-kickback and other fraud and abuse law matters as well as on patient privacy matters, including HIPAA, 42 CFR Part 2 and corresponding state-level compliance. Amy also assists with internal investigations and assessing and responding to the results, including developing corrective action recommendations and self-disclosures.
A sought-after speaker and prolific writer on some of the most complex and critical issues in healthcare law, Amy shares her insights in publications and presentations across the country. She co-authored chapters in numerous publications, including the telemedicine chapter of the American Bar Association’s Physician Law: Evolving Trends & Hot Topics and a chapter addressing telehealth in the MCLE Massachusetts Health and Hospital Law Manual.
Chambers USA notes that Amy has “deep expertise in matters that impact healthcare providers and healthcare transactions,” “is a terrific resource on a range of regulatory issues” and “an expert in the Stark Law.”
Amy graduated first in her class at UCLA Law and was elected to the Order of the Coif. Prior to law school, Amy served in the U.S. Air Force.
Boston
Amy works with digital health companies, health systems and other public and private companies—from new entrants to seasoned organizations—to address regulatory compliance and transactional needs. She also advises investors and collaborates with clients to understand their business goals and tailor practical solutions to help them achieve those objectives. Amy is well-versed in the corporate governance, data privacy, and security and scope-of-practice considerations facing the healthcare industry as it incorporates artificial intelligence (AI) and machine-learning (ML) solutions into clinical workflows. Her practice includes structuring and scaling national telehealth practices across a range of clinical disciplines, including complex collaborative arrangements involving labs, medical device manufacturers, remote patient monitoring solutions and pharmacies.
Amy spends much of her time working with clients on vetting and developing strategic affiliations, joint venture transactions and other novel business arrangements, including developing value-based enterprises and otherwise identifying means to achieve further alignment among stakeholders. She advises on reimbursement issues with respect to federal healthcare programs, private payors and self-pay business models. She also helps develop compliance programs and advises on related protocols and best practices.
In particular, Amy advises on physician self-referral, anti-kickback and other fraud and abuse law matters as well as on patient privacy matters, including HIPAA, 42 CFR Part 2 and corresponding state-level compliance. Amy also assists with internal investigations and assessing and responding to the results, including developing corrective action recommendations and self-disclosures.
A sought-after speaker and prolific writer on some of the most complex and critical issues in healthcare law, Amy shares her insights in publications and presentations across the country. She co-authored chapters in numerous publications, including the telemedicine chapter of the American Bar Association’s Physician Law: Evolving Trends & Hot Topics and a chapter addressing telehealth in the MCLE Massachusetts Health and Hospital Law Manual.
Chambers USA notes that Amy has “deep expertise in matters that impact healthcare providers and healthcare transactions,” “is a terrific resource on a range of regulatory issues” and “an expert in the Stark Law.”
Amy graduated first in her class at UCLA Law and was elected to the Order of the Coif. Prior to law school, Amy served in the U.S. Air Force.
London
David's experience primarily includes renewable energy projects (onshore and offshore wind, solar PV, energy-from-waste and green hydrogen) and other energy transition projects (including carbon capture, usage and storage) with a particular focus on M&A, joint ventures and project development. He also has experience advising on governance, regulatory and ESG-related matters.
London
David's experience primarily includes renewable energy projects (onshore and offshore wind, solar PV, energy-from-waste and green hydrogen) and other energy transition projects (including carbon capture, usage and storage) with a particular focus on M&A, joint ventures and project development. He also has experience advising on governance, regulatory and ESG-related matters.